Archives of Nephrology and Renal Studies
Peritoneal Imaging may be the Last Piece of the Puzzle for Precision Evaluation of Peritoneal Function
Due to changes in end-stage renal disease (ESRD) policies in many countries and the impact of COVID-19, the importance and demand for peritoneal dialysis (PD) as a home dialysis treatment modality is growing prominently . However, peritoneal membrane dysfunction remains a bottleneck restricting the application of PD. Therefore, there is an urgent need to develop new methods to accurately assess peritoneal function.Arch Nephrol Ren Stud, 2022, Volume 2, Issue 1, p6-8 | DOI: 10.33696/nephrology.2.007
The RiVUR Study Outcomes and Implications on the Management of Vesicoureteral Reflux
The Randomized intervention for Vesicoureteral Reflux (RiVUR) study was an effort by the National Institute of Health to identify the most significant question on the management of vesicoureteral reflux (VUR), i.e. Did antibiotic prophylaxis reduce the incidence of recurrent urinary tract infections (UTI) in children with VUR? During the initial phases of the RiVUR study, several similar studies were performed that seemed to indicate lack of benefit of antibiotic prophylaxis in VUR.Arch Nephrol Ren Stud, 2022, Volume 2, Issue 1, p1-5 | DOI: 10.33696/nephrology.2.006
How Well Do Hemodialysis Patients Respond to the BNT162b2 mRNA COVID-19 Vaccine?
In January 2020, the World Health Organization (WHO) classified COVID-19 to be a Public Health Emergency of International Concern and declared it a pandemic on March 11, 2020 . Over one hundred and eighty-five million people have been infected by SARS-CoV-2 and roughly four million have died worldwide so farArch Nephrol Ren Stud, 2021, Volume 1, Issue 1, p21-27 | DOI: 10.33696/nephrology.1.004
Safety of Using Rituximab Therapy During COVID-19 Pandemic
Rituximab is a chimeric (20% rodent and 80% human) monoclonal antibody that binds to the CD20 antigen present on the cell surface and leads to depletion of mature B-cells [1,2]. It is the first approved monoclonal antibody to be used in the therapy of indolent B-cell non- Hodgkin’s lymphoma and chronic lymphocytic leukemiaArch Nephrol Ren Stud, 2021, Volume 1, Issue 1, p10-15 | DOI: 10.33696/nephrology.1.002
Percutaneous Ablation of Localized Renal Masses: An Updated Review
With readily available cross-sectional imaging, asymptomatic localized renal masses (LRMs) are often incidentally found. The standard management for LRM has been surgical resection, however, detection of masses that are benign or with low metastatic risk has led to interest in minimally invasive alternatives such as percutaneous thermal ablation (TA) or active surveillanceArch Nephrol Ren Stud, 2021, Volume 1, Issue 1, p1-9 | DOI: 10.33696/nephrology.1.001
Scientific Archives is a global publisher initiated with the mission of ensuring equal opportunity for accessing science to research community all over the world. Spreading research findings with great relevance to all channels without any barrier is our goal. We want to overcome the challenges of Open Access with ensured quality and transparency.